• Illinois: The American Medical Association (AMA) recently updated its maternity care coding, a change the organization called the "most significant" move in decades to improve care delivery and data for maternal health. In the update, AMA removed 17 current procedural terminology (CPT) codes, created six new codes, and revised six codes. The changes, which were developed over almost two years, will go into effect Jan. 1, 2027. "Physicians cannot improve what they cannot measure," said AMA president Willie Underwood. "These CPT revisions give physicians, researchers, and policymakers a clearer understanding of the care mothers receive throughout pregnancy and after delivery, helping identify opportunities to improve quality, strengthen accountability, and improve outcomes for mothers and babies." (Gleeson, Fierce Healthcare, 7/6)
• Indiana: Elevance Health has invested over $1 billion in affordable housing over the last roughly 20 years, including $640 million in the past five years. So far, Elevance has invested in around 400 properties, which support over 40,000 affordable housing units in 45 states, the District of Columbia, Puerto Rico, and Guam. In the last five years, its investments include 15 properties with 2,654 affordable housing units in 10 different states. According to Aimée Daily, president of government health benefits at Elevance, the investments are part of the organization's efforts to address social drivers of health, lower total cost of care, and increase access to stable housing for people who may be facing barriers to care. "Our continued investment reflects a long-term commitment to addressing the underlying factors that impact overall health," Dailey said. "By focusing on high-impact housing initiatives and strong local partnerships, we are helping individuals and families achieve stability, improve their health, reduce avoidable healthcare costs and create a foundation for long-term wellbeing." (Bender, Healthcare Finance, 6/23)
• New York: According to a new study published in Nature Medicine, general-purpose AI tools from OpenAI, Google, and Anthropic were able to outperform specialized clinical AI tools in several medical benchmarks. For the study, researchers tested OpenAI's GPT-5.2, Google's Gemini 3.1 Pro, and Anthropic's Claude Opus 4.6 against OpenEvidence and Wolter Kluwer's UpToDate Expert AI. The tools were tested in three stages: 500 MedQA knowledge questions, 500 HealthBench items that measured clinician alignment, and 100 real clinical queries from physicians at NYU Langone Health who used a HIPAA-compliant GPT instance. Overall, the general-purpose models outperformed the specialized clinical models in all three stages. According to the researchers, the findings have implications for procurement, reimbursement, and regulatory oversight of clinical AI tools. Both OpenEvidence and Wolters Kluwer have disputed the findings, with OpenEvidence saying that the study was vulnerable to "contamination effects" and asking for a retraction. However, Eric Oermann, a physician and the study's senior author, said that the researchers "continue to stand by our study and its results." (Bruce, Becker's Health IT, 6/16)

Generative artificial intelligence is poised to transform healthcare, with potential applications ranging from near-term to revolutionary. Use this field guide to discover how 11 possible use cases could shape the industry and the role of your organization.